Table 2. Change in PTSD (CAPS) Severity Over Time.
VRE-DCS (n=13) | VRE-placebo (n=12) | P Value (95% CI) | |
---|---|---|---|
Mean (SD) | N Mean (SD) | (Percent change) | |
Pre-treatment | 81.62 (22.13) | 75.08 (23.80) | |
3A assessment | 65.84 (16.99) | 65.67 (23.65) | |
Percent change at 3A | 16.05 (21.72) | 9.99 (28.31) | p=0.552 (−26.83, 14.71) |
6A assessment | 58.07 (20.69) | 63.83 (24.70) | |
Percent change at 6A | 45.86 (15.41) | 29.59 (24.94) | p=0.060 (−33.26, 0.74) |
10A assessment | 45.46 (31.95) | 52.17 (19.96) | |
Percent change at 10A | 55.94 (16.54) | 41.69 (21.27) | p=0.073 (−29.94, 1.45) |
Post-treatment | 32.38 (28.55) | 42.17 (20.75) | |
Percent change at post-treatment | 61.92 (25.88) | 42.89 (22.45) | p=0.063 (−39.16, 1.09) |
Six-month follow-up | 24.15 (26.48) | 45.92 (25.66) | |
Percent change at 6-month follow-up | 74.85 (23.53) | 37.64 (33.94) | p=0.004 (−61.20, −13.21) |
Percent change was calculated relative to pre-treatment.